Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
EDAP
EDAP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EDAP News
EDAP Appoints David Horn to Board of Directors
4d ago
Newsfilter
EDAP Reports Record 2025 HIFU Revenue, Issues 2026 Guidance for 36%-38% Growth
Jan 12 2026
Globenewswire
EDAP Reports Record 2025 HIFU Revenue, Issues 2026 Guidance for 36%-38% Growth
Jan 12 2026
Newsfilter
EDAP Receives FDA 510(k) Clearance for Enhanced Focal One HIFU System
Nov 24 2025
Newsfilter
GNTA, BBIO, AMRN Surge in After-Hours Trading: Major Biotech Factors Fueling Stock Increases
Oct 29 2025
NASDAQ.COM
Natural Killer Cell Treatments Drive $254B Shift in Immunotherapy Market
Oct 17 2025
Newsfilter
EDAP Secures HIFU Reimbursement for Prostate Cancer Treatment in France
Sep 08 2025
Newsfilter
EDAP TMS S.A. announces second quarter results
Aug 28 2025
SeekingAlpha
EDAP Unveils Letter of Intent for €36 Million Credit Facility to Boost Growth and Strategic Development
Aug 26 2025
Newsfilter
This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Apr 04 2025
Benzinga
This Dow Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Apr 04 2025
Benzinga
Jefferies Downgrades Edap TMS to Hold, Lowers Price Target to $2
Apr 04 2025
Benzinga
EDAP TMS Reports Positive Data From FARP Study In Prostate Cancer
Apr 01 2025
NASDAQ.COM
Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
Feb 06 2025
Newsfilter
EDAP Appoints Joshua H. Levine to Board of Directors
Jan 10 2025
Yahoo Finance
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
Dec 04 2024
Newsfilter
Show More News
